Health Care

Why Healthcare Investors Shouldn’t Bank on Drug Pipelines

by Vinay Thapar, CFA, Co-Chief Investment Officer and Senior Research Analyst—US Growth Equities; Portfolio Manager—Global Healthcare, AllianceBernstein Healthcare…

Keep Your Eye on the CAR-T

by Christopher Gannatti, CFA Global Head of Research, WisdomTree Key Takeaways Despite weak public biotech stock performance, venture…

Where it pays to get choosy: A case study in stock selection

by Tony DeSpirito, Managing Director, Global Chief Investment Officer, Fundamental Equities, & Ibrahim Kanan, Healthcare sector lead, Fundamental…

The health care breakthrough that’s not an obesity drug

by Richmond Wolf, Christopher Lee, Judith Finegold, Capital Group You’ve heard of computer hacking, now meet gene hacking.…

What’s right with the world

by Jared Franz, Jeff Garcia & Carl Kawaja, Capital Group A daily diet of negative news can lead…

Weighty Matters

by Carl Tannebaum, Chief Economist, Northern Trust 2024 is upon us. We hope that the old year concluded…

Weight loss drugs could reshape industries beyond health care

by Michael Beckwith, Greg Wendt, and Laura Nelson Carney, Capital Group From deep-fried turkey to pumpkin pie, the…

Big Picture: Investors Not on the Defensive, Despite Talk of Recession

by Abhishek Ashok, M.A., MFE, CFA®, Analyst, AGF Investments Inc. Consumer staples, healthcare and utilities sectors have underperformed…

AOH1996: Breakthrough Cancer-Killing Drug or Just Another Hype?

“The fact that hype exists doesn't prove that something is not important.” – Vilayanur Ramachandran This sentiment is the…

Will AI Transform the Healthcare Industry for Investors?

by Vinay Thapar, CFA| Co-Chief Investment Officer and Senior Research Analyst—US Growth Equities; Portfolio Manager—Global Healthcare, AllianceBernstein Healthcare…